Copeland Jan, Allsop David
National Cannabis Prevention and Information Centre, UNSW Medicine, University of New South Wales, Sydney, Australia.
Drug Alcohol Rev. 2014 Sep;33(5):565-71. doi: 10.1111/dar.12166. Epub 2014 Jun 6.
Over the past decade, there has been significant investment in dedicated cannabis-only treatment clinics in New South Wales. This study aims to describe the characteristics of clients and compares first-time treatment seeking history and treatment completion rates between dedicated and non-dedicated clinics.
An observational study of administrative information from 209,012 drug and alcohol treatment episodes from services reporting to the New South Wales Alcohol and Other Drug Treatment Services Minimum Dataset, July 2003-June 2008.
Across all episodes, cannabis was the second most prevalent primary drug of concern (17.8%, n = 37,242). The majority of clients primarily seeking treatment for cannabis were male (69.4%, 26,088), with a mean age of 29 years. Counselling was the most common cannabis treatment (34.1%, n = 12,713), with 11.6% (n = 1476) of those receiving counselling having done so at a cannabis clinic. Those treated in cannabis clinics were older (30.12 years vs. 27.95 years; P < 0.0001); had shorter episode durations (10.95 weeks vs. 12.71 weeks; P < 0.0001); and were more likely to be naïve to treatment (53.7% vs. 47.7%; P < 0.0001). Indigenous Australian treatment seekers were more likely to complete cannabis treatment in a dedicated cannabis clinic (49.6%) than in a non-dedicated clinic (40.5%; P < 0.05).
Cannabis clinics have attracted groups traditionally difficult to attract and retain in treatment. As the cohort of daily cannabis users age, it is important that service models are attractive to older clients, new to treatment. Rigorous, prospective research examining client treatment outcomes are now warranted.
在过去十年中,新南威尔士州对专门的仅提供大麻治疗的诊所进行了大量投资。本研究旨在描述客户的特征,并比较专门诊所和非专门诊所首次寻求治疗的历史以及治疗完成率。
一项观察性研究,对2003年7月至2008年6月向新南威尔士州酒精和其他药物治疗服务最低数据集报告服务的209,012次药物和酒精治疗事件的行政信息进行分析。
在所有事件中,大麻是第二大最普遍的主要关注药物(17.8%,n = 37,242)。主要寻求大麻治疗的客户大多数为男性(69.4%,26,088),平均年龄为29岁。咨询是最常见的大麻治疗方式(34.1%,n = 12,713),其中11.6%(n = 1476)接受咨询的人是在大麻诊所进行的。在大麻诊所接受治疗的人年龄较大(30.12岁对27.95岁;P < 0.0001);治疗时间较短(10.95周对12.71周;P < 0.0001);并且更可能是初次接受治疗(53.7%对47.7%;P < 0.0001)。澳大利亚原住民寻求治疗者在专门的大麻诊所完成大麻治疗的可能性(49.6%)高于在非专门诊所(40.5%;P < 0.05)。
大麻诊所吸引了传统上难以在治疗中吸引和留住的群体。随着每日大麻使用者群体的老龄化,服务模式对初次接受治疗的老年客户具有吸引力非常重要。现在有必要进行严格的前瞻性研究来检查客户的治疗结果。